Rising Cancer Cases Drive Demand For Cancer Vaccines: A Key Driver Powering Cancer Vaccines Market Growth In 2025

The Cancer Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_
_x000D_
What Is the Current Cancer Vaccines Market Size and Its Estimated Growth Rate?_x000D_
The cancer vaccines market has grown rapidly in recent years. It will grow from $7.22 billion in 2024 to $8.25 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. This market growth is driven by the increasing incidence of cancer, greater awareness of cancer vaccines, the expanding range of approved vaccines, growing evidence of their efficacy, and government support for research and development._x000D_
_x000D_
The cancer vaccines market is set for rapid growth, expected to reach $13.89 billion in 2029 at a CAGR of 13.9%. Growth is fueled by personalized and combination therapies, pharma investments, biomarker discovery, and wider vaccine adoption. Trends include neoantigen-based vaccines, therapeutic cancer vaccines, immunological advancements, and collaborative R&D._x000D_
_x000D_
Purchase the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3452_x000D_
_x000D_
How Are Emerging Segments Shaping the Cancer Vaccines Market Landscape?_x000D_
The cancer vaccines market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines_x000D_
2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines_x000D_
3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types_x000D_
4) By End-User: Cancer Treatment Centers, Research Institutes_x000D_
_x000D_
Subsegments:_x000D_
1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines_x000D_
2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp_x000D_
_x000D_
Which Growth Factors Are Influencing Cancer Vaccines Market Expansion?_x000D_
Rising cancer cases worldwide are projected to drive growth in the cancer vaccines market during the forecast period. According to the American Cancer Society in January 2022, there were likely 1.9 million new cancer diagnoses and 609,360 deaths in the US. Lung, prostate, bowel, and female breast cancers made up 43% of new cases globally. This rising prevalence is expected to boost demand for cancer vaccines in the coming years._x000D_
_x000D_
Who Are the Dominant Players Across Different Cancer Vaccines Market Segments?_x000D_
Major companies operating in the cancer vaccines market include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc._x000D_
_x000D_
What Cancer Vaccines Market Trends Are Gaining Traction Across Different Segments?_x000D_
The growing popularity of alternative treatments and natural remedies is impacting the revenues of cancer vaccine manufacturers. Therapies like homeopathy, Ayurveda, yoga, and acupuncture are gaining traction, leading to a shift away from some traditional treatments. Ayurveda, for instance, uses herbal remedies with anti-cancer properties. The WHO notes that some countries still rely heavily on plant-based treatments, and developing nations are increasingly turning to natural remedies, which affects cancer vaccine sales. The global homeopathic market is projected to reach $18.6 billion by 2027, further limiting cancer vaccine demand._x000D_
_x000D_
Get the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report_x000D_
_x000D_
Which Geographic Regions Are Expected to Dominate the Cancer Vaccines Market in the Coming Years?_x000D_
The countries covered in the cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_
_x000D_
Frequently Asked Questions:_x000D_
1. What Is the Market Size and Growth Rate of the Cancer Vaccines Market?_x000D_
2. What is the CAGR expected in the Cancer Vaccines Market?_x000D_
3. What Are the Key Innovations Transforming the Cancer Vaccines Industry?_x000D_
4. Which Region Is Leading the Cancer Vaccines Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.